Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prenatal screening for Down syndrome

R F Ogle1, L S Chitty

  • 1Department of Fetal Medicine, Obstetric Hospital, University College Hospital, London.

Hospital Medicine (London, England : 1998)
|November 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The incremental yield of prenatal exome sequencing over chromosome microarray for congenital heart abnormalities: A systematic review and meta-analysis.

Prenatal diagnosis·2024
Same author

Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Evidence to Support the Clinical Utility of Prenatal Exome Sequencing in Evaluation of the Fetus with Congenital Anomalies: Scientific Impact Paper No. 64 [February] 2021.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Non-invasive prenatal diagnosis and screening for monogenic disorders.

European journal of obstetrics, gynecology, and reproductive biology·2020
Same author

COngenital heart disease and the Diagnostic yield with Exome sequencing (CODE) study: prospective cohort study and systematic review.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same journal

Management of non-thrombolysable acute coronary syndrome (ACS).

Hospital medicine (London, England : 1998)·2005
Same journal

Case report: treatment of faecaloma of the colon.

Hospital medicine (London, England : 1998)·2005
Same journal

Should anaesthetists scrub? The case for and against.

Hospital medicine (London, England : 1998)·2005
Same journal

Angiosarcoma: a difficult diagnosis.

Hospital medicine (London, England : 1998)·2005
Same journal

Pitfalls in recurrent varicose vein surgery.

Hospital medicine (London, England : 1998)·2005
Same journal

Aorto-caval fistula.

Hospital medicine (London, England : 1998)·2005
See all related articles

This review examines Down syndrome screening programs for pregnancies. It discusses current methods, their pros and cons, and future research directions for improved aneuploidy detection.

Area of Science:

  • Prenatal diagnostics and genetic screening
  • Maternal-fetal medicine
  • Public health screening programs

Background:

  • Numerous screening programs exist to detect pregnancies at high risk for aneuploidy, specifically Down syndrome.
  • Combining serum biochemical markers and ultrasound in screening can complicate risk interpretation in general populations.
  • Accurate risk assessment is crucial for appropriate prenatal care and management.

Purpose of the Study:

  • To review existing Down syndrome screening programs.
  • To analyze the advantages and limitations of current screening methodologies.
  • To identify potential areas for future research in Down syndrome screening.

Main Methods:

  • Literature review of current Down syndrome screening strategies.

Related Experiment Videos

  • Analysis of data regarding the efficacy and limitations of various screening tests.
  • Synthesis of information on first and second-trimester screening approaches.

    • Main Results:

    • Current screening programs vary in their effectiveness and applicability to unselected populations.
    • The integration of biochemical and ultrasound markers presents challenges in risk interpretation.
    • There is a need for clearer guidelines and improved methods for Down syndrome screening.

    Conclusions:

    • Down syndrome screening programs require ongoing evaluation and refinement.
    • Further research is needed to enhance the accuracy and reduce the complexity of prenatal aneuploidy screening.
    • Optimizing screening protocols can lead to better outcomes for pregnancies at risk for Down syndrome.